These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15180459)

  • 21. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety.
    Emami S; Foroumadi A; Faramarzi MA; Samadi N
    Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and synthesis of modified quinolones as antitumoral acridones.
    Tabarrini O; Cecchetti V; Fravolini A; Nocentini G; Barzi A; Sabatini S; Miao H; Sissi C
    J Med Chem; 1999 Jun; 42(12):2136-44. PubMed ID: 10377219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospects for developing new antibacterials targeting bacterial type IIA topoisomerases.
    Tomašić T; Mašič LP
    Curr Top Med Chem; 2014; 14(1):130-51. PubMed ID: 24236722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde.
    Anderson VE; Osheroff N
    Curr Pharm Des; 2001 Mar; 7(5):337-53. PubMed ID: 11254893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lethal fragmentation of bacterial chromosomes mediated by DNA gyrase and quinolones.
    Malik M; Zhao X; Drlica K
    Mol Microbiol; 2006 Aug; 61(3):810-25. PubMed ID: 16803589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fluoroquinolones: Non-antibacterial properties].
    Leyva-Ramos S; Hernández-López H
    Rev Esp Quimioter; 2017 Feb; 30(1):1-8. PubMed ID: 27976571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Amino-7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6,8-difluoro-1,4- dihydro-4-oxo-3-quinolinecarboxylic acid (PD 124,816). Synthesis and biological evaluation of a new class of quinolone antibacterials.
    Domagala JM; Hagen SE; Hutt MP; Sanchez JP; Sesnie J; Trehan AK
    Drugs Exp Clin Res; 1988; 14(7):453-60. PubMed ID: 2853667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoroquinolone-dependent DNA supercoiling by Vaccinia topoisomerase I.
    Kamau E; Grove A
    J Mol Biol; 2004 Sep; 342(2):479-87. PubMed ID: 15327948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoroquinolone-Gyrase-DNA Cleaved Complexes.
    Luan G; Drlica K
    Methods Mol Biol; 2018; 1703():269-281. PubMed ID: 29177748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-substituted piperazinyl sarafloxacin derivatives: synthesis and in vitro antibacterial evaluation.
    Asadipour A; Moshafi MH; Khosravani L; Moghimi S; Amou E; Firoozpour L; Ilbeigi G; Beiki K; Soleimani E; Foroumadi A
    Daru; 2018 Dec; 26(2):199-207. PubMed ID: 30392156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in the discovery and development of quinolones and analogs as antitumor agents.
    Xia Y; Yang ZY; Morris-Natschke SL; Lee KH
    Curr Med Chem; 1999 Mar; 6(3):179-94. PubMed ID: 10219099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual targeting of topoisomerase IV and gyrase to reduce mutant selection: direct testing of the paradigm by using WCK-1734, a new fluoroquinolone, and ciprofloxacin.
    Strahilevitz J; Hooper DC
    Antimicrob Agents Chemother; 2005 May; 49(5):1949-56. PubMed ID: 15855518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 6-Aminoquinolones as new potential anti-HIV agents.
    Cecchetti V; Parolin C; Moro S; Pecere T; Filipponi E; Calistri A; Tabarrini O; Gatto B; Palumbo M; Fravolini A; Palu' G
    J Med Chem; 2000 Oct; 43(20):3799-802. PubMed ID: 11020296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7 H- pyridol[1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161).
    Coughlin SA; Danz DW; Robinson RG; Klingbeil KM; Wentland MP; Corbett TH; Waud WR; Zwelling LA; Altschuler E; Bales E
    Biochem Pharmacol; 1995 Jun; 50(1):111-22. PubMed ID: 7605336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereo (C7)-dependent topoisomerase II inhibition and tumor growth suppression by a new quinolone, BO-2367.
    Yoshinari T; Mano E; Arakawa H; Kurama M; Iguchi T; Nakagawa S; Tanaka N; Okura A
    Jpn J Cancer Res; 1993 Jul; 84(7):800-6. PubMed ID: 8396568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. QSAR study and VolSurf characterization of anti-HIV quinolone library.
    Filipponi E; Cruciani G; Tabarrini O; Cecchetti V; Fravolini A
    J Comput Aided Mol Des; 2001 Mar; 15(3):203-17. PubMed ID: 11289075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quinolone mode of action--new aspects.
    Hooper DC
    Drugs; 1993; 45 Suppl 3():8-14. PubMed ID: 7689456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel N-2-(Furyl)-2-(chlorobenzyloxyimino) Ethyl Piperazinyl Quinolones: Synthesis, Cytotoxic Evaluation and Structure-Activity Relationship.
    Mohammadhosseini N; Pordeli M; Safavi M; Firoozpour L; Amin F; Kabudanian Ardestani S; Edraki N; Shafiee A; Foroumadi A
    Iran J Pharm Res; 2015; 14(4):1095-103. PubMed ID: 26664376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral 6-amino-quinolones: molecular basis for potency and selectivity.
    Richter SN; Gatto B; Tabarrini O; Fravolini A; Palumbo M
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4247-51. PubMed ID: 16054362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quinolone-based drugs against Toxoplasma gondii and Plasmodium spp.
    Anquetin G; Greiner J; Vierling P
    Curr Drug Targets Infect Disord; 2005 Sep; 5(3):227-45. PubMed ID: 16181142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.